KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Moderna (MRNA) Preferred Shares Issued (2018)

Historic Preferred Shares Issued for Moderna (MRNA) over the last 1 years, with Q2 2018 value amounting to $111.6 million.

  • Moderna's Preferred Shares Issued changed N/A to $111.6 million in Q2 2018 from the same period last year, while for Mar 2019 it was $111.6 million, marking a year-over-year change of. This contributed to the annual value of $661.1 million for FY2018, which is N/A changed from last year.
  • Moderna's Preferred Shares Issued amounted to $111.6 million in Q2 2018.
  • In the past 5 years, Moderna's Preferred Shares Issued registered a high of $549.5 million during Q1 2018, and its lowest value of $111.6 million during Q2 2018.